Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Neogenomics Inc (NASDAQ: NEO) was $8.11 for the day, up 3.44% from the previous closing price of $7.84. In other words, the price has increased by $3.44 from its previous closing price. On the day, 1.25 million shares were traded.
Ratios:
Our analysis of NEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.45.
On April 30, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 12 ’25 when Stone Warren bought 5,700 shares for $8.58 per share. The transaction valued at 48,895 led to the insider holds 108,280 shares of the business.
TETRAULT LYNN A. bought 7,000 shares of NEO for $56,974 on May 09 ’25. The Director now owns 7,000 shares after completing the transaction at $8.14 per share. On May 07 ’25, another insider, KANOVSKY STEPHEN M, who serves as the Director of the company, bought 4,000 shares for $7.78 each. As a result, the insider paid 31,124 and bolstered with 40,090 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.55 while its Price-to-Book (P/B) ratio in mrq is 1.17.
Stock Price History:
Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is -10.67%, while the 200-Day Moving Average is calculated to be -40.47%.
Shares Statistics:
A total of 128.36M shares are outstanding, with a floating share count of 127.02M. Insiders hold about 1.30% of the company’s shares, while institutions hold 100.00% stake in the company.
